What This Means for Peptide Therapy Patients Peptide compounds like Sermorelin or CJC-1295/Ipamorelin are increasingly used for: Anti-aging protocols Post-injury recovery Energy, sleep, and muscle support But without understanding IGFBP-3, these therapies may: Look falsely effective (if IGF-1 rises but free IGF-1 is excessive) Pose hidden risks (if protective binding is insufficient) We use IGF-1 : IGFBP-3 ratio analysis as a tool for: Refining dosage Adjusting protocols Monitoring cancer risk Supporting safe, individualized regenerative therapies Functional Testing in a Root-Cause Framework At Internal Healing & Wellness MD, we use advanced lab testing to interpret growth hormone signaling, assess whole-body function, and guide individualized protocols
PMC 503720
'What about this?' he asked
Side effects, adverse reactions and escalation protocols
This compound actually transports fatty acids into the mitochondria of cells, which is where cells get their energy
Full publication of combination-therapy data is awaited, however interim analysis from the phase II COURAGE trial (NCT06299098) found 3.3% reduction in lean mass of obese patients treated with the combination of trevogrumab and semaglutide, compared with 6.5% reduction with semaglutide alone [70]